Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study

Declining antimicrobial susceptibility to current gonorrhoea antibiotic treatment and inadequate treatment options have raised the possibility of untreatable gonorrhoea. New prevention approaches, such as vaccination, are needed. Outer membrane vesicle meningococcal serogroup B vaccines might be pro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet infectious diseases 2022-07, Vol.22 (7), p.1021-1029
Hauptverfasser:	Abara, Winston E, Bernstein, Kyle T, Lewis, Felicia M T, Schillinger, Julia A, Feemster, Kristen, Pathela, Preeti, Hariri, Susan, Islam, Aras, Eberhart, Michael, Cheng, Iris, Ternier, Alexandra, Slutsker, Jennifer Sanderson, Mbaeyi, Sarah, Madera, Robbie, Kirkcaldy, Robert D
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Antiinfectives and antibacterials Antimicrobial agents Chlamydia Chlamydia Infections Condoms Cross-protection Data analysis Disease prevention Epidemics Gonorrhea Gonorrhea - epidemiology Gonorrhea - prevention & control Humans Immunization Infections Infectious diseases Licenses Membranes Meningococcal Infections - prevention & control Meningococcal Vaccines Neisseria gonorrhoeae Neisseria meningitidis, Serogroup B Observational studies Prevention Regression analysis Serogroup Sexually transmitted diseases Sociodemographics STD Surveillance Vaccination Vaccines Young adults
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!